Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model
Preclinical data published in Frontiers in Immunology, a leading peer-reviewed journal Induction of pro-inflammatory…
Preclinical data published in Frontiers in Immunology, a leading peer-reviewed journal Induction of pro-inflammatory…
Wissenschaftler:innen des Universitätsklinikums Hamburg-Eppendorf (UKE) haben kreuzreaktive Immunantworten auf ein wei…
Direct MagnetOs sales climbed from CHF 2.0 million in Q1 2022 to CHF 5.4 million in Q1 2023. Total medical device sales…
HeiQ Blue and Ridge Home Fashions are engaging in a partnership to incorporate multiple innovative textile technologies…
Publications in peer reviewed Journal of Immunology and Regenerative Medicine and Clinical Oral Implants Research Adds…
Nomad Bioscience GmbH, Munich, Germany (“NOMAD”) is pleased to announce that the Company has extended its research and d…
BioEcho has developed a novel product reflecting the company belief that even the most routine molecular biology protoco…
Allero Therapeutics BV, a Dutch oromucosal immunotherapy company, today announced that the Company has received a EUR 2.…
Prof. Dr. Ralf Huss will become the new managing director of BioM Biotech Cluster Development GmbH, effective of January…
Wissenschaftler:innen des Universitätsklinikums Hamburg-Eppendorf (UKE) veröffentlichen neueste Erkenntnisse aus klini…